Mamedyarov Zaur
Pharmaceutical Industry Development in the Midst of Crisis: Global Trends. MIR (Modernization. Innovation. Research). 2020;11(4):398-408.
Publication Type:

ISSN 2079-4665

DOI: 10.18184/2079-4665.2020.11.4.398-408

Purpose: the main purpose of the article was to study the trends in the global pharmaceutical industry, as one of the most knowledge-intensive in the world economy, against the background of the 2020 COVID-related crisis. The task was to study the impact of the economic crisis on the priorities of the largest pharmaceutical multinationals, to link them with trends in the restructuring of health care systems, as well as to analyze and assess the potential impact of Brexit on the European pharma industry, starting from 2021. Methods: the work is based on a comparative analysis of trends in the restructuring of global value chains in pharmaceuticals, the digitalization of pharmaceuticals and health care, as well as a quantitative analysis of the revenue and value added by the largest European pharmaceutical multinational companies. Results: the COVID-19 pandemic has accelerated the process of digitalization of big pharma; the intensified transition to a continuous production model can be expected in the coming years. Also, the second largest industry market, the EU-27, will suffer less from Brexit than the UK itself, and industries in developing countries will benefit from additional growth opportunities. The digitalization of healthcare remains an important underlying factor for the transformation of pharmaceuticals and further growth of innovation competition. This paper presents the problems of pharma and how to address them, as well as possible ways to restructure healthcare systems to reduce the likelihood of new pandemics - this will be at the heart of regulatory solutions in the medium term. Сonclusions and Relevance: governments and state regulators will be actively involved in the process of recovery of the pharmaceutical industry after the crisis. For small regional pharmaceutical producers in developing countries there is a growing need to digitalize production and diversify supply chains. Implementation of continuous production technologies allows expecting growth in the number of small pharmaceutical producers, deepening competition in the industry. The Brexit deal will also have significant implications for the industry, leading to a restructuring of supply chains within the EU from early 2021, reducing the UK's competitiveness.

Keywords: pharmaceutical industry | pharma R&D | regulation of pharma | innovation policy | Brexit |

Russian Science Citation Index


Mamedyarov Zaur
Public Innovation Policy in the Pharmaceutical Industry: the Cases of the EU and USA

Mamedyarov Zaur
Тенденции и перспективы российской фармацевтической отрасли и применимость мирового опыта [Текст] / З.А. Мамедьяров // МИР (Модернизация. Инновации. Развитие). – 2017. – Т. 8. – № 4s(32s). – С. 772-780.

Sheliubskaya Nataliya
Брекзит и научно-техническая политика ЕС // Инновации. 2020. № 9. С. 86-90. DOI 10.26310/2071-3010.2020.263.9.011.

Baikov N.
Капиталовложения в нефтегазовую отрасль разных стран на 2008 г. / Н.М. Байков // Нефтяное хозяйство = Neftyanoe Khozyaistvo - Oil Industry. – 2008. – № 7. – С. 140–141.

Selyanin Yaroslav
Management System in the U.S.: the Case of AI-Related Projects // USA & Canada: Economics – Politics – Culture. – 2022. – Issue 9 C. 95-113 .

Pankova Ludmila
Evolution of the USA Defense Research and Development: Amount and Structure of Financing

Ivanova Natalya, Mamedyarov Zaur
Pharmaceutical industry in Russia: Key trends and developments

Gusarova Olga
The R&D Contracting System in the UK Defense and Security

Gilkova Olga
Милитаризация науки и ее влияние на развитие экономики [Текст] / О. Н Гилькова // Современная наука: актуальные проблемы теории и практики. Серия: экономика и право. – 2018. – № 1. – С. 78-81.

Ivanova Natalya
Будущее в настоящем / Н.И. Иванова // Прямые инвестиции. – 2008. – № 5. – С. 4-7.

Shultseva Vera
Умные цепочки в цифровой упаковке // Электросвязь. 2020. № 12. С. 46-49. DOI 10.34832/ELSV.2020.13.12.006.

Kutsyna Elena
Системный подход к исследованию инноваций в военно-промышленном комплексе развитых стран / Е.А. Куцына // Вооружение и экономика. – 2011. – № 15. – С. 63-72.

Kutsyna Elena
R&D and innovation in the military sector of the United Kingdom economy. Moscow, IMEMO PAN, 2014. – 42 p.

Yevtodyeva Marianna
Japan: New Trends in Research and Development of Defense and Dual-Use Technologies

Zenkov Alexey
Цифровизация образования: направления, возможности, риски // Вестник Воронежского государственного университета. Серия: проблемы высшего образования. 2020. № 1. С. 52-55.

Ivanova Natalya
Innovation is an Economic Measure for Progress…

Ivanova Natalya
Бумажный тигр (о проекте МЭР «Инновационная Россия – 2020») / Н.И. Иванова // Инновации. – 2011. – № 2. – С. 3–4.

Bogacheva Olga
Актуальные вопросы организации государственного финансирования НИОКР в странах ОЭСР [Текст] / О. В. Богачева, О. В. Смородинов // Научно-исследовательский финансовый институт. Финансовый журнал. – 2019. – № 2 (48). – С. 37-50. DOI: 10.31107/2075-1990-2019-2-37-50.

Shultseva Vera
Цифровой апгрейд мировой экономики: "взрыв созидательного разрушения" [Текст] / В.К. Шульцева // Электросвязь. – 2017. – № 8. – С. 41-46.

Bogacheva Olga, Feoktistova O.A.
State R&D Assignments: Approach to Determining their Budgets Based Normative Costs
Related publications

Comments (0)

No comments

Add comment

First news
Institute News

On February 27, 2024, the website of the Russian International Affairs Council published an article by Ivan Shchedrov "In the Struggle for 'Heavy Luxury': How the Tourism Industry Became a Subject of the Dispute in India-Maldives Relations".



The Primakov National Research Institute of World Economy and International Relations (IMEMO) of the Russian Academy of Sciences held an expert meeting with the University of Mumbai and Observer Research Foundation (ORF) in Mumbai.


Recently Published